Brief: Delcath Systems Extends Term Of Agreement To December 31, 2028
April 26 (Reuters) - Delcath Systems Inc DCTH.O :
* DELCATH SYSTEMS INC - EXTENDS THE TERM OF THE AGREEMENT TO
DECEMBER 31, 2028
* DELCATH SYSTEMS INC - MODIFIES THE PRICE PER VIAL FOR THE
PRODUCT
* DELCATH SYSTEMS: ON APRIL 22, CO AMENDED, EFFECTIVE MAY 1,
TO
LICENSE, SUPPLY AND CONTRACT MANUFACTURING DEAL WITH SYNERX
PHARMA AND MYLAN TEORANTA
* DELCATH SYSTEMS INC - AMENDMENT TO AGREEMENT WITH SYNERX
PHARMA,
LLC AND MYLAN TEORANTA, FOR CO'S SUPPLY OF MELPHALAN
HYDROCHLORIDE
Source text for Eikon: ID:n0001193125-24-115922
Further company coverage: DCTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Delcath Systems
See all newsBrief: Delcath Systems Highlights Clinical Program Presentations At Esmo Congress 2026 And Independent Data On Percutaneous Hepatic Perfusion In Liver-Dominant Metastatic Uveal Melanoma
Brief: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule
Delcath Systems Inc reports results for the quarter ended June 30 - Earnings Summary
Delcath Systems Q2 revenue rises, beats estimates
Delcath Systems Inc expected to post a loss of 9 cents a share - Earnings Preview